It has been shown in colorectal cancer that NLRP3 activation can enhance antitumor immunity by promoting NK cell activity and IL-18/IFN-γ signaling, whereas microbiota-driven dysregulation of NLRP3/GSDMD may instead support tumorigenesis through disrupted signaling [281]. This evidence concerns the gene GSDMD and colorectal cancer.